• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis.

作者信息

Van Ackerbroeck Sofie, Rutsaert Lynn, Roelant Ella, Dillen Kathleen, Wauters Joost, Van Regenmortel Niels

机构信息

Department of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen Campus Stuivenberg, Lange Beeldekensstraat 267, 2060, Antwerp, Belgium.

Department of Haematology, Gasthuiszusters Antwerpen, Campus St. Augustinus, Oosterveldlaan 24, 2610, Wilrijk, Belgium.

出版信息

Crit Care. 2021 Aug 19;25(1):298. doi: 10.1186/s13054-021-03728-w.

DOI:10.1186/s13054-021-03728-w
PMID:34412686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8374123/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/8375067/a91cb32496a5/13054_2021_3728_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/8375067/a91cb32496a5/13054_2021_3728_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7280/8375067/a91cb32496a5/13054_2021_3728_Fig1_HTML.jpg

相似文献

1
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis.吸入性脂质体两性霉素B作为COVID-19相关肺曲霉病/曲霉气管支气管炎的预防性治疗。
Crit Care. 2021 Aug 19;25(1):298. doi: 10.1186/s13054-021-03728-w.
2
Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.吸入两性霉素B预防侵袭性曲霉感染。
Ann Pharmacother. 2006 Dec;40(12):2148-54. doi: 10.1345/aph.1G477. Epub 2006 Dec 5.
3
[Aspergillosis in pulmonary transplantation].[肺移植中的曲霉病]
Enferm Infecc Microbiol Clin. 2000 May;18(5):209-14.
4
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.雾化脂质体两性霉素B预防长期中性粒细胞减少期间侵袭性肺曲霉病：一项随机、安慰剂对照试验
Clin Infect Dis. 2008 May 1;46(9):1401-8. doi: 10.1086/586739.
5
Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients.雾化两性霉素B用于粒细胞缺乏患者侵袭性曲霉病的预防
Bone Marrow Transplant. 1990 Jun;5(6):403-6.
6
10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.雾化脂质体两性霉素B预防治疗10年与肺移植曲霉属感染流行病学的变化
Transpl Int. 2016 Jan;29(1):51-62. doi: 10.1111/tri.12679. Epub 2015 Oct 12.
7
Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation.小剂量两性霉素B预防异基因骨髓移植患者侵袭性曲霉感染
Am J Med. 1991 Nov;91(5):484-92. doi: 10.1016/0002-9343(91)90184-y.
8
Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.雾化脂质体两性霉素B在治疗烟曲霉脓胸中的应用。
Thorax. 1995 Dec;50(12):1321-3. doi: 10.1136/thx.50.12.1321.
9
Characterization of amphotericin B aerosols for inhalation treatment of pulmonary aspergillosis.用于肺部曲霉病吸入治疗的两性霉素B气雾剂的特性研究
Infection. 1996 Sep-Oct;24(5):354-60. doi: 10.1007/BF01716078.
10
Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF.脂质体两性霉素、吸入用两性霉素B、γ干扰素和粒细胞巨噬细胞集落刺激因子成功治疗流感后假膜性坏死性支气管曲霉病
Thorax. 1999 Nov;54(11):1047-9. doi: 10.1136/thx.54.11.1047.

引用本文的文献

1
Efficacy and Safety of Amphotericin B Colloidal Dispersion via Nebulized Inhalation Combined with Intravenous Therapy for Invasive Pulmonary Fungal Disease: A Single-Center, Retrospective Cohort Study.雾化吸入两性霉素B胶体分散剂联合静脉治疗侵袭性肺真菌病的疗效与安全性：一项单中心回顾性队列研究
Infect Drug Resist. 2025 Jul 10;18:3415-3425. doi: 10.2147/IDR.S519105. eCollection 2025.
2
SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.两性霉素B增强严重急性呼吸综合征冠状病毒2感染：对疾病管理的启示
J Virol. 2025 Jul 22;99(7):e0051925. doi: 10.1128/jvi.00519-25. Epub 2025 Jun 4.
3

本文引用的文献

1
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病诊断与临床管理特别工作组报告
Intensive Care Med. 2021 Aug;47(8):819-834. doi: 10.1007/s00134-021-06449-4. Epub 2021 Jun 23.
2
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病：2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
3
COVID-19-associated invasive pulmonary aspergillosis.
Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024.
迈向肺部感染的整体治疗方法。来自2024年西班牙专家第六届年会的见解。
Rev Esp Quimioter. 2025 Mar 27;38(3):152-186. doi: 10.37201/req/017.2025.
4
Invasive Aspergillosis in the Intensive Care Unit.重症监护病房中的侵袭性曲霉病
J Fungi (Basel). 2025 Jan 17;11(1):70. doi: 10.3390/jof11010070.
5
Posaconazole for Prevention of COVID-19-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case-Control Study (POSACOVID).泊沙康唑预防机械通气患者新型冠状病毒肺炎相关肺曲霉病：一项欧洲多中心病例对照研究（POSACOVID）
Mycoses. 2025 Jan;68(1):e70023. doi: 10.1111/myc.70023.
6
Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis.研究方案：一项关于isavuconazole预防新冠病毒相关肺曲霉病的随机、双盲、安慰剂对照试验。
Contemp Clin Trials Commun. 2024 May 17;39:101310. doi: 10.1016/j.conctc.2024.101310. eCollection 2024 Jun.
7
[Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry].[采用在线二维高效液相色谱-四极杆飞行时间质谱法对两性霉素B进行杂质谱分析]
Se Pu. 2024 Apr 8;42(5):432-444. doi: 10.3724/SP.J.1123.2023.07012.
8
Severe mold fungal infections in critically ill patients with COVID-19.COVID-19 重症患者的严重霉菌真菌感染。
Future Microbiol. 2024 Jun 12;19(9):825-840. doi: 10.2217/fmb-2023-0261. Epub 2024 May 31.
9
Amphotericin B in the Era of New Antifungals: Where Will It Stand?新型抗真菌药物时代的两性霉素B：它将何去何从？
J Fungi (Basel). 2024 Apr 10;10(4):278. doi: 10.3390/jof10040278.
10
Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis.整合遗传和免疫因素以揭示病毒相关性肺曲霉病的发病机制。
mBio. 2024 Jun 12;15(6):e0198223. doi: 10.1128/mbio.01982-23. Epub 2024 Apr 23.
新型冠状病毒肺炎相关侵袭性肺曲霉病
Ann Intensive Care. 2020 Jun 1;10(1):71. doi: 10.1186/s13613-020-00686-4.
4
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update.吸入两性霉素B用于血液系统疾病曲霉病预防的最新进展
Microbiol Insights. 2019 Aug 28;12:1178636119869937. doi: 10.1177/1178636119869937. eCollection 2019.
5
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病：一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.
6
Are the frail destined to fail? Frailty index as predictor of surgical morbidity and mortality in the elderly.虚弱的人注定会失败吗？虚弱指数预测老年人的手术发病率和死亡率。
J Trauma Acute Care Surg. 2012 Jun;72(6):1526-30; discussion 1530-1. doi: 10.1097/TA.0b013e3182542fab.